Trials / Completed
CompletedNCT04036812
Superficial Cervical Plexus Block for Postoperative Analgesia
Ultrasound Guided Superficial Cervical Plexus Block for Analgesia After Craniotomy Via Suboccipital Retrosigmoid Approach: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The incidence of postoperative pain after craniotomy is high. Severe postoperative pain can lead to a series of complications that are detrimental to the recovery of craniotomy patients. Compound local scalp nerve block is a good choice for analgesia after craniotomy. However, the scalp nerve block commonly cannot cover the area of suboccipital retrosigmoid approach craniotomy, leading to incomplete block. Superficial cervical plexus block (SCPB) is theoretically promising to solve the analgesia requirements of such surgical approach. At the same time, ultrasound guidance can not only accurately locate, ensure the effect of block and avoid accidental injury during puncture. The purpose of this study is to explore whether ultrasound-guided superficial cervical plexus block can safely and effectively reduce the requirement of analgesic drugs and pain after craniotomy via suboccipital retrosigmoid approach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Superficial cervical plexus block | superficial cervical plexus nerve block will be performed under the guidance of ultrasound |
| OTHER | Control group | ultrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml normal saline. |
Timeline
- Start date
- 2019-11-18
- Primary completion
- 2021-04-09
- Completion
- 2021-04-10
- First posted
- 2019-07-30
- Last updated
- 2025-02-13
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04036812. Inclusion in this directory is not an endorsement.